Jointly sponsored/co-provided by Postgraduate Institute for Medicine and The Scleroderma Foundation.
Virginia Steen, M.D., Georgetown University Medical Center, Washington, D.C., Moderator
Philip Clements, M.D., UCLA Medical Center, Los Angeles, CA
Aryeh Fischer, M.D., National Jewish Health, Denver, CO
8:00 a.m. - 8:45 a.m. Registration & Breakfast
8:45 a.m. - 9:30 a.m. Pulmonary Fibrosis in Scleroderma- Philip Clements, M.D.
9:30 a.m. - 10:15 a.m. PH in Scleroderma - Aryeh Fischer, M.D.
10:15 a.m. - 10:30 a.m. Break
10:30 a.m. - 11:00 a.m. Panel Discussion: Dr. Clements, Dr. Fischer, and Dr. Steen, Moderator
11:00 a.m. - 11:15 a.m. Bring Your Case
Attendees will have an opportunity to discuss their cases with the panel
PRE-REGISTRATION IS REQUIRED. Please register for this event by Friday, July 26 by clicking on the link below. Or contact Kerri A. Connolly at firstname.lastname@example.org.
will be to raise awareness about early diagnosis of SSc-pulmonary
hypertension and SSc- interstitial lung disease to discuss ways
to effectively treat and manage the conditions. This will involve
recent/appropriate/updated knowledge dissemination to clinicians and
activity has been designed to meet the educational needs of physicians,
registered nurses, and other health care professionals involved in the
management of patients with scleroderma.
After completing this activity, the participant should be better able to:
- Develop material to increase awareness about the need for early
diagnosis and treatment of pulmonary hypertension and interstitial
fibrosis in systemic sclerosis.
- Implement recent updates on the
diagnostic methods and outcome measures used in scleroderma patients
with pulmonary hypertension or interstitial fibrosis.
special circumstances where evaluation of prognosis and appropriate
modification of treatment requires additional debate/discussion.
There is no fee for this educational activity. Hotel valet parking will be validated.
Physician Continuing Medical Education
activity has been planned and implemented in accordance with the
Essential Areas and policies of the Accreditation Council for Continuing
Medical Education through the joint sponsorship of Postgraduate
Institute for Medicine and The Scleroderma Foundation. The Postgraduate
Institute for Medicine is accredited by the ACCME to provide continuing
medical education for physicians.
Postgraduate Institute for Medicine designates this live activity for a
maximum of 2.25 AMA PRA Category 1 Credit(s)™. Physicians should claim
only the credit commensurate with the extent of their participation in
Nursing Continuing Education
This educational activity for 2.2 contact hours is provided by Postgraduate Institute for Medicine.
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Disclosure of Conflicts of Interest
Institute for Medicine (PIM) requires instructors, planners, managers
and other individuals who are in a position to control the content of
this activity to disclose any real or apparent conflict of interest
(COI) they may have as related to the content of this activity. All
identified COI are thoroughly vetted and resolved according to PIM
policy. The existence or absence of COI for everyone in a position to
control content will be disclosed to participants prior to the start of
Americans with Disabilities Act
staff will be glad to assist you with any special needs (ie, physical,
dietary, etc). Please contact Kerri A. Connolly prior to the live event
A statement of credit will be issued only upon
receipt of a completed activity evaluation form and will be mailed to
you within three weeks.
This activity is supported by an educational grant from Actelion Pharmaceuticals US